Komori
S

SOFTMAX CO.,LTD

3671Information and Communications, Services and OthersMicro cap
300JPY-1.0%
★ Watch (sign-up required)
Price history
¥300Latest+39.3%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview

During the interim accounting period, the Company continued to develop, sell, implement and maintain healthcare DX-related systems, including cloud-based electronic medical records, with a focus on the medical information systems sector. As its core product, it provides a web-based electronic medical record system on a public cloud using a data center and on a private cloud for hospitals within the Group, adopting a public cloud environment registered on the ISMAP Cloud Services List. In research and development, the Company is advancing demonstration trials of the latest technologies, including generative AI, and pursuing initiatives that support documentation in healthcare settings and improve operational efficiency. In line with policies promoting the digitalization of healthcare and healthcare DX, these initiatives continue to provide a significant medium-term tailwind from both supply and demand. The Company is continuing to capture customer replacement demand and invest in the development of new functions.

Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
Loading
Documents
See all timely disclosuresSee all statutory filings
News
See all news
Key numbersShowing 8 of 20
PER
30.04How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.
PBR
1.9How many times the company's net assets? Around 1x is generally considered a benchmark.
ROE
6.3%Earning power. A figure above 10% is generally considered good.
Dividend yield
0.0%The annual dividend as a percentage of the share price.
Market capitalization
¥7.5bnShare price × number of shares. The value of the entire company.
Equity ratio
46.1%The proportion of assets funded by money that does not have to be repaid.
Operating margin
8.7%The percentage of revenue remaining from the company’s core business.
Revenue growth (3 years)
23.1%The average annual growth in sales over the past three years.
What to watch next
The transition of generative AI, including medical document drafting support, summarization and suggested diagnoses, from proof-of-concept testing to live product functionality, as shown by implementation results and customer deployments
Impact MediumLikelihood Medium
A phase in which the adoption of environments using ISMAP-listed cloud services raises the likelihood of selection for public-sector and healthcare DX projects and accelerates the acquisition of new implementations and replacement projects
Impact MediumLikelihood Medium
Improvement in operating margin and FCF as the company enters the monetization phase following capital expenditures, particularly the acquisition of land and buildings in 2026
Impact HighLikelihood Low
What to watch next
Loading
Who owns itTop holders total 67.3%
Listed holders 67.3%Everyone else 32.7%
株式会社リンクス24.90%
Nomura Toshiro (野村俊郎)21.30%
HIKARI TSUSHIN KK Investment Limited Liability Partnership (funded by HIKARI TSUSHIN,INC.)5.20%
株式会社鹿児島銀行4.00%
株式会社青雲3.40%
Rakuten Securities, Inc. (shared account)2.90%
ソフトマックス従業員持株会1.70%
槇田重夫1.50%
2 other listed holders2.40%
Who owns it
HolderOwnership (%)
株式会社リンクス24.90
Nomura Toshiro (野村俊郎)21.30
HIKARI TSUSHIN KK Investment Limited Liability Partnership (funded by HIKARI TSUSHIN,INC.)5.20
株式会社鹿児島銀行4.00
株式会社青雲3.40
Rakuten Securities, Inc. (shared account)2.90
ソフトマックス従業員持株会1.70
槇田重夫1.50
2 other listed holders2.40
This company's documents
Filings
Timely disclosures
Threads